amikacin has been researched along with mezlocillin in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (72.73) | 18.7374 |
1990's | 4 (18.18) | 18.2507 |
2000's | 2 (9.09) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Ramírez-Rivera, J; Rivera-Rivera, R | 1 |
Anak, S; Devecioğlu, O; Gedikoğlu, G; Ovali, F; Zülfikar, B | 1 |
Le Faou, A; Warter, S | 1 |
Debbia, EA; Molinari, G; Paglia, P; Pesce, A | 1 |
Ramirez-Ronda, CH; Rivera-Vazquez, CR; Rodriguez, JR; Saavedra, S | 1 |
Klastersky, J; Van Laethem, Y | 1 |
Adelman, RD; Rubio, T; Wirth, F | 1 |
Bouillet, L; Husson, MO; Izard, D; Leclerc, H | 1 |
Aujard, Y; Bingen, E; Guihaire, E; Lambert-Zechovsky, N; Mancy, C; Mathieu, H | 1 |
Chao, HP; Guenthner, SH; Wenzel, RP | 1 |
Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR | 1 |
Jeljaszewicz, J; Ko, HL; Pulverer, G; Roszkowski, K; Roszkowski, W | 1 |
Antón Aranda, E; Asín Marcotegui, JL; Tiberio López, G; Unzué Gaztelu, JJ | 1 |
Goering, RV; Sanders, CC; Sanders, WE; Werner, V | 1 |
Klastersky, J | 1 |
Aznar, J; Iglesias, MC; Martin, E; Nogales, MC; Perea, EJ | 1 |
Gerding, DN; Moody, JA; Peterson, LR | 1 |
Barry, AL; Gavan, TL; Jones, RN; Thornsberry, C | 1 |
Pickering, LK; Rutherford, I | 1 |
Höffler, D | 1 |
3 trial(s) available for amikacin and mezlocillin
Article | Year |
---|---|
The efficacy of mezlocillin-amikacin combination in febrile neutropenic children with oncologic disease.
Topics: Adolescent; Amikacin; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Haemophilus Infections; Humans; Infant; Male; Mezlocillin; Neisseriaceae Infections; Neoplasms; Neutropenia; Staphylococcal Infections; Streptococcal Infections | 1991 |
A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Aztreonam; Bacterial Infections; Clindamycin; Clinical Trials as Topic; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Male; Mezlocillin; Middle Aged; Pneumonia; Random Allocation; Tobramycin | 1989 |
A controlled study of the nephrotoxicity of mezlocillin and amikacin in the neonate.
Topics: Amikacin; Bacterial Infections; Clinical Trials as Topic; Female; Humans; Infant, Newborn; Kidney; Male; Mezlocillin; Random Allocation | 1987 |
19 other study(ies) available for amikacin and mezlocillin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Infected bullae: a recognizable entity.
Topics: Amikacin; Clindamycin; Corynebacterium; Corynebacterium Infections; Cysts; Drug Therapy, Combination; Humans; Lung; Lung Diseases; Male; Mezlocillin; Middle Aged; Radiography; Sputum | 1992 |
Value of a novel antibiotic association for the study of sperm motility in vitro.
Topics: Amikacin; Drug Therapy, Combination; Humans; In Vitro Techniques; Male; Mezlocillin; Penicillins; Sperm Motility; Streptomycin | 1990 |
Dactimicin, a new aminoglycoside: in vitro activity, post-antibiotic effect and interaction with other antibiotics.
Topics: Acinetobacter; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Ceftazidime; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Mezlocillin; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Time Factors | 1989 |
Serum bactericidal activity of mezlocillin, ceftazidime, mezlocillin/ceftazidime and mezlocillin/amikacin against Klebsiella pneumoniae and Pseudomonas aeruginosa.
Topics: Amikacin; Ceftazidime; Drug Evaluation; Drug Synergism; Humans; Kanamycin; Klebsiella pneumoniae; Mezlocillin; Pseudomonas aeruginosa | 1986 |
In vitro activity of pefloxacin.
Topics: Amikacin; Anti-Infective Agents; Cefotaxime; Ceftazidime; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance | 1986 |
[Optimum choice of antibiotic treatment in neonatal infections due to group B streptococci].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Gentamicins; Humans; Infant, Newborn; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Streptococcal Infections; Streptococcus agalactiae | 1986 |
Synergy between amikacin and ticarcillin or mezlocillin against nosocomial bloodstream isolates.
Topics: Amikacin; Bacteria; Cross Infection; Drug Synergism; Humans; Mezlocillin; Penicillins; Ticarcillin | 1986 |
Mezlocillin, ceftizoxime, and amikacin alone and in combination against six Enterobacteriaceae in a neutropenic site in rabbits.
Topics: Agranulocytosis; Amikacin; Animals; Cefotaxime; Ceftizoxime; Drug Combinations; Enterobacteriaceae; Female; Hydrogen-Ion Concentration; Kanamycin; Mezlocillin; Microbial Sensitivity Tests; Neutropenia; Rabbits | 1985 |
Antibiotics and immunomodulation: effects of cefotaxime, amikacin, mezlocillin, piperacillin and clindamycin.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Antibody Formation; Cefotaxime; Clindamycin; Hypersensitivity, Delayed; Immune System; Immunosuppressive Agents; In Vitro Techniques; Lymphocyte Activation; Male; Mezlocillin; Mice; Mice, Inbred BALB C; Piperacillin | 1985 |
[Our experience in the treatment of peritonitis in ambulatory chronic peritoneal dialysis with mezlocillin and amikacin].
Topics: Adolescent; Amikacin; Child; Drug Therapy, Combination; Humans; Kanamycin; Male; Mezlocillin; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1985 |
Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Enterobacter; Enterobacteriaceae; Humans; Klebsiella pneumoniae; Mezlocillin; Mutation; Nalidixic Acid; Norfloxacin; Penicillin Resistance; Quinolines | 1984 |
Treatment of severe infections in patients with cancer. The role of new acyl-penicillins.
Topics: Amikacin; Azlocillin; Bacterial Infections; Drug Therapy, Combination; Humans; Mezlocillin; Neoplasms; Penicillins; Piperacillin | 1982 |
Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Cefsulodin; Cephalosporins; Dibekacin; Drug Synergism; Gentamicins; Mezlocillin; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1980 |
In vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Azlocillin; Bacteria; Cephalosporins; Drug Interactions; Kanamycin; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa | 1984 |
In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosides.
Topics: Amikacin; Ampicillin; Azlocillin; Bacteria; Carbenicillin; Gentamicins; Kanamycin; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Ticarcillin | 1980 |
Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin.
Topics: Amdinocillin; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Gentamicins; Mezlocillin; Netilmicin; Penicillins; Piperacillin; Time Factors; Tobramycin | 1981 |
Control and duration of therapy in complicated UTI--with special consideration of C-reactive protein.
Topics: Amikacin; C-Reactive Protein; Drug Administration Schedule; Drug Therapy, Combination; Escherichia coli; Female; Humans; Mezlocillin; Middle Aged; Urinary Tract Infections | 1994 |